NCT00389584View on ClinicalTrials.gov

Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Brain and Central Nervous System TumorsCognitive/Functional EffectsLong-term Effects Secondary to Cancer Therapy in AdultsLong-term Effects Secondary to Cancer Therapy in ChildrenPoor Performance StatusUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

irinotecan hydrochloride

PROCEDURE

cognitive assessment

PROCEDURE

management of therapy complications

RADIATION

radiation therapy

Trial Locations (1)

95817

University of California Davis Cancer Center, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT00389584 - Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors | Biotech Hunter | Biotech Hunter